BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/6/2017 8:30:21 PM | Browse: 1403 | Download: 3013
Publication Name World Journal of Gastroenterology
Manuscript ID 30363
Country Sweden
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus
Manuscript Source Unsolicited Manuscript
All Author List Francisco Baldaque-Silva, Michael Vieth, Mumen Debel, Bengt Håkanson, Anders Thorell, Nuno Lunet, Huan Song, Miguel Mascarenhas-Saraiva, Gisela Pereira, Lars Lundell and Hanns-Ulrich Marschall
Funding Agency and Grant Number
Corresponding Author Francisco Baldaque-Silva, MD, Gastrocentrum, Institute of Medicine, Karolinska Institutet, Karolinska University Hospital, Karolinska vägen, 14186 Stockholm, Sweden. fbaldaquesilva@gmail.com
Key Words Barrett’s esophagus; Acid reflux; Proton pump inhibitors; Health related quality of life; Gastroesophageal reflux; Symptom control; Antireflux surgery
Core Tip This study evaluated the effects of increasing, acid-reflux-adjusted doses of proton pump inhibitors (PPI) on symptoms and histology in Barrett’s eso­phagus (BE) patients in comparison to BE patients with a clinically successful fundoplication. All patients went through an extensive prospective protocol with symptom assessment, upper endoscopy with biopsies, 24 h pH-monitoring and manometry. In the non-operated group, 42% of patients needed more than the standard PPI dose to reach acid control which then was associated with improvement of symptom scores up to the same levels as after successful fundoplication. In addition, acid reflux control was associated with changes in the esophageal columnar and squamous epithelium, regardless of medical or surgical treatment.
Publish Date 2017-05-06 20:30
Citation Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183
URL http://www.wjgnet.com/1007-9327/full/v23/i17/3174.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i17.3174
Full Article (PDF) WJG-23-3174.pdf
Full Article (Word) WJG-23-3174.doc